Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase (Q43821570)

27 November 2017

Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase (English)

1 reference

27 November 2017

Takashi Miki

1

1 reference

27 November 2017

Masakuni Kori

2

1 reference

27 November 2017

Akira Fujishima

3

1 reference

27 November 2017

Hiroshi Mabuchi

4

1 reference

27 November 2017

Ryu ichi Tozawa

5

1 reference

27 November 2017

Masahira Nakamura

6

1 reference

27 November 2017

Yasuo Sugiyama

7

1 reference

27 November 2017

Hidefumi Yukimasa

8

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bioorganic & Medicinal Chemistry

27 November 2017

1 reference

27 November 2017

10

1 reference

27 November 2017

2

1 reference

27 November 2017

385-400

1 reference

Consensus conference. Lowering blood cholesterol to prevent heart disease

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Inhalation of levomepromazine in severe acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

New approaches to atherosclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Myotonia induced by diazacholesterol: increased (Na+ + K+)-ATPase activity of erythrocyte ghosts and development of cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Inhibitors of squalene biosynthesis and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Combating cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Truncation of human squalene synthase yields active, crystallizable protein

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

The benzodiazepine story

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

An opioid benzodiazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Platelet-Activating Factor-Induced Aggregation of Human Platelets Specifically Inhibited by Triazolobenzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

A novel 3-substituted benzazepinone growth hormone secretagogue (L-692,429)

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 1. Synthesis and evaluation of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and analogues as potential antidepressant agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 2. Nuclear-substituted analogues of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and (+/-)-4,5-dihydro-2-ethyl-3-methyl-4-phenyl-3H-1,3-benzodiazepine as potential antidepressant agen

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Synthesis and angiotensin converting enzyme inhibitory activity of 1,5-benzothiazepine and 1,5-benzoxazepine derivatives. I

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Extension of the Modified Stobbe Condensation. Acid-Catalyzed Decomposition of the Products and a Lacto—Enoic Tautomerism1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Benzazepinones. Synthesis of the monoaza analog of diazepam, and the correct structure of the benzoylpropionanilide cyclization product

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Potent NK1 receptor antagonists: synthesis and antagonistic activity of various heterocycles with an N-[3,5-bis(trifluoromethyl)benzyl]-N-methylcarbamoyl substituent.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Synthesis of 3-ureido derivatives of coumarin and 2-quinolone as potent acyl-CoA: cholesterol acyltransferase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Regulation of squalene synthetase activity in rat liver: elevation by cholestyramine, but no diurnal variation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

Synthesis of allylic and homoallylic isoprenoid pyrophosphates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900289-9

7 January 2021

10.1016/S0968-0896(01)00289-9

Identifiers

DOI

1 reference

27 November 2017

1 reference